FR3135892B1 - traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient - Google Patents

traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient Download PDF

Info

Publication number
FR3135892B1
FR3135892B1 FR2205148A FR2205148A FR3135892B1 FR 3135892 B1 FR3135892 B1 FR 3135892B1 FR 2205148 A FR2205148 A FR 2205148A FR 2205148 A FR2205148 A FR 2205148A FR 3135892 B1 FR3135892 B1 FR 3135892B1
Authority
FR
France
Prior art keywords
ards
patient
respiratory distress
distress syndrome
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR2205148A
Other languages
English (en)
Other versions
FR3135892A1 (fr
Inventor
Freitas Caires Nathalie De
Philippe Lassalle
Maxence Hureau
Alexandre Gaudet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biothelis
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
Centre Hospitalier Universitaire de Lille
Institut Pasteur
Université de Lille
Original Assignee
Biothelis
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
Centre Hospitalier Regional Universitaire de Lille CHRU
Institut Pasteur
Université de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biothelis, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Regional Universitaire de Lille CHRU, Institut Pasteur, Université de Lille filed Critical Biothelis
Priority to FR2205148A priority Critical patent/FR3135892B1/fr
Priority to PCT/FR2023/050744 priority patent/WO2023233095A1/fr
Publication of FR3135892A1 publication Critical patent/FR3135892A1/fr
Application granted granted Critical
Publication of FR3135892B1 publication Critical patent/FR3135892B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient L’invention concerne ESM-1 (Endothelial cell Specific Molecule) ou composition pharmaceutique en contenant pour utilisation dans une méthode de traitement ou de prévention d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient.
FR2205148A 2022-05-30 2022-05-30 traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient Expired - Fee Related FR3135892B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2205148A FR3135892B1 (fr) 2022-05-30 2022-05-30 traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient
PCT/FR2023/050744 WO2023233095A1 (fr) 2022-05-30 2023-05-26 Traitement d'un syndrome de detresse respiratoire aigue (sdra) chez un patient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2205148 2022-05-30
FR2205148A FR3135892B1 (fr) 2022-05-30 2022-05-30 traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient

Publications (2)

Publication Number Publication Date
FR3135892A1 FR3135892A1 (fr) 2023-12-01
FR3135892B1 true FR3135892B1 (fr) 2024-06-14

Family

ID=82694096

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2205148A Expired - Fee Related FR3135892B1 (fr) 2022-05-30 2022-05-30 traitement d’un syndrome de détresse respiratoire aiguë (SDRA) chez un patient

Country Status (2)

Country Link
FR (1) FR3135892B1 (fr)
WO (1) WO2023233095A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
FR2775691B1 (fr) 1998-03-05 2000-12-15 Pasteur Institut Anticorps monoclonaux specifiques de la proteine esm-1, et utilisation de ces anticorps pour la detection de la proteine esm-1
FR2816410B1 (fr) 2000-11-09 2003-04-18 Pasteur Institut Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire

Also Published As

Publication number Publication date
FR3135892A1 (fr) 2023-12-01
WO2023233095A1 (fr) 2023-12-07

Similar Documents

Publication Publication Date Title
Grobbelaar et al. Relative hypercoagulopathy of the SARS-CoV-2 beta and delta variants when compared to the less severe omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness
Mao et al. Reactivation of senescence-associated endogenous retroviruses by ATF3 drives interferon signaling in aging
Ackerman IV et al. Comprehensive RNA profiling of villous trophoblast and decidua basalis in pregnancies complicated by preterm birth following intra-amniotic infection
Tratwal et al. Influence of vascular endothelial growth factor stimulation and serum deprivation on gene activation patterns of human adipose tissue-derived stromal cells
Allen et al. Voriconazole enhances the osteogenic activity of human osteoblasts in vitro through a fluoride-independent mechanism
Cicconi et al. Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy
Cicero et al. 18th Century knowledge on microbial attacks on parchment: analytical and historical evidence
Miyamoto et al. Axial mechanical loading to ex vivo mouse long bone regulates endochondral ossification and endosteal mineralization through activation of the BMP-Smad pathway during postnatal growth
Caetano da Silva et al. WNT11, a new gene associated with early onset osteoporosis, is required for osteoblastogenesis
Salvaggio et al. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients
Tang et al. lncRNA IGF2‐AS promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by sponging miR‐3,126‐5p to upregulate KLK4
Kovács et al. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin
Ye et al. Integrative Analysis of ceRNA Networks in human periodontal ligament stem cells under hypoxia
Yu et al. CD63 and C3AR1: the potential molecular targets in the progression of septic shock
Huang et al. Cord blood-derived biologics lead to robust axonal regeneration in benzalkonium chloride-injured mouse corneas by modulating the Il-17 pathway and neuropeptide Y
Ghose et al. Genome-wide association neural networks identify genes linked to family history of Alzheimer’s disease
Choi et al. Prediction of medication-related osteonecrosis of the jaws using machine learning methods from estrogen receptor 1 polymorphisms and clinical information
Soobryan et al. The role and expression of pro/antiangiogenic factors and microRNAs in gestational hypertension and pre-eclampsia
Yamada et al. Identification of EGFLAM, SPATC1L and RNASE13 as novel susceptibility loci for aortic aneurysm in Japanese individuals by exome-wide association studies
Spellmann et al. Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients
Kornsuthisopon et al. Interleukin 15 participates in Jagged1-induced mineralization in human dental pulp cells
Lin et al. Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303/cochlin axis
He et al. The “toxic window” of amoxicillin exposure during pregnancy on long bone development in fetal mice
Ding et al. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC–EHRA EORP AF Long-Term General Registry
Li et al. Rutin promotes osteogenic differentiation of mesenchymal stem cells (MSCs) by increasing ECM deposition and inhibiting p53 expression

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20231201

ST Notification of lapse

Effective date: 20250106